CMA accuses Pfizer, Flynn of overcharging NHS for phenytoin sodium capsules
The Competition and Markets Authority (CMA) has accused Pfizer and Flynn of overcharging the NHS for vital anti-epilepsy drugs, after reassessing the case.
According to...
CMA slaps Advanz with £100 million in fines for over pricing of thyroid drug
The Competition and Markets Authority (CMA) has imposed more than £100 million in fines on Advanz for inflating the price of thyroid tablets.
The pharma...